A computational model for predicting integrase catalytic domain of retrovirus.

J Theor Biol

School of Electronic and Information Engineering, Xi'an Jiaotong University, Xi'an 710049, China.

Published: June 2017

Integrase catalytic domain (ICD) is an essential part in the retrovirus for integration reaction, which enables its newly synthesized DNA to be incorporated into the DNA of infected cells. Owing to the crucial role of ICD for the retroviral replication and the absence of an equivalent of integrase in host cells, it is comprehensible that ICD is a promising drug target for therapeutic intervention. However, annotated ICDs in UniProtKB database have still been insufficient for a good understanding of their statistical characteristics so far. Accordingly, it is of great importance to put forward a computational ICD model in this work to annotate these domains in the retroviruses. The proposed model then discovered 11,660 new putative ICDs after scanning sequences without ICD annotations. Subsequently in order to provide much confidence in ICD prediction, it was tested under different cross-validation methods, compared with other database search tools, and verified on independent datasets. Furthermore, an evolutionary analysis performed on the annotated ICDs of retroviruses revealed a tight connection between ICD and retroviral classification. All the datasets involved in this paper and the application software tool of this model can be available for free download at https://sourceforge.net/projects/icdtool/files/?source=navbar.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtbi.2017.04.020DOI Listing

Publication Analysis

Top Keywords

integrase catalytic
8
catalytic domain
8
icd retroviral
8
annotated icds
8
icd
7
computational model
4
model predicting
4
predicting integrase
4
domain retrovirus
4
retrovirus integrase
4

Similar Publications

Article Synopsis
  • HIV-1 infection remains a major global health issue, with around 30 million individuals receiving antiretroviral treatment, where integrase strand-transfer inhibitors (INSTIs) play a key role in effective therapy.
  • The research focuses on evaluating the off-target effects of clinically approved INSTIs on recombinase activating genes (RAG1 and RAG2), crucial for the immune system, using various biochemical and cellular tests.
  • Results indicate that approved INSTIs have minimal to no adverse effects on RAG activity and V(D)J recombination, supporting their continued use in HIV-1 treatment without significant immune system concerns.
View Article and Find Full Text PDF
Article Synopsis
  • AR, an Ayurvedic botanical, was studied for its effects on HIV-1 replication and its ability to reduce mitochondrial dysfunction during infection.
  • Both AR root extracts and its main active compound, Shatavarin IV, showed non-toxic, dose-dependent inhibition of HIV-1 in laboratory tests, particularly effective against certain viral subtypes.
  • Shatavarin IV interacted with key enzymes involved in HIV-1 replication, suggesting its potential as a therapeutic agent, while also helping to alleviate mitochondrial damage caused by the virus.
View Article and Find Full Text PDF

Allosteric HIV-1 integrase (IN) inhibitors (ALLINIs) are investigational antiretroviral agents that potently impair virion maturation by inducing hyper-multimerization of IN and inhibiting its interaction with viral genomic RNA. The pyrrolopyridine-based ALLINI pirmitegravir (PIR) has recently advanced into phase 2a clinical trials. Previous cell culture-based viral breakthrough assays identified the HIV-1 variant that confers substantial resistance to this inhibitor.

View Article and Find Full Text PDF

Quinolinonyl Derivatives as Dual Inhibitors of the HIV-1 Integrase Catalytic Site and Integrase-RNA interactions.

ACS Med Chem Lett

September 2024

Dipartimento di Chimica e Tecnologie del Farmaco, Istituto Pasteur-Fondazione Cenci Bolognetti, "Sapienza" Università di Roma, p.le Aldo Moro 5, I-00185 Rome, Italy.

The HIV-1 integrase (IN) plays a critical role in the viral lifecycle by integrating the viral DNA into the host chromosome. The catalytic function of IN has been exploited as a target, with five drugs acting as active site binders (IN strand transfer inhibitors, INSTIs). However, IN mutations conferring low-level resistance to INSTIs have been reported.

View Article and Find Full Text PDF

Effective intracellular delivery of therapeutic proteins can potentially treat a wide array of diseases. However, efficient delivery of functional proteins across the cell membrane remains challenging. Exosomes are nanosized vesicles naturally secreted by various types of cells and may serve as promising nanocarriers for therapeutic biomolecules.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!